BIO-Key International (BKYI) Stock Price

BIO-Key International Price

NASDAQ·CLOSED
2.76
​
Market closed

Revenue at BIO-Key International has contracted by 4.7% per year over the past 19 years to 6.10 M USD. Earnings per share have declined at 89.5% per year over the last 4 years. BIO-Key International's net margin stands at -75.3%, up from -99.0% several years earlier. Analysts set a median price target of 2.04 USD, implying 26.1% below the current price. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.

BIO-Key International stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BIO-Key International business model & stock analysis

BIO-Key International Inc, headquartered in Wall Township, New Jersey, operates in the Information Technology sector, specializing in fingerprint biometric technology and security software solutions. The company develops automated identification systems that complement traditional verification methods like passwords, smart cards, and PKI. Its solutions enable secure access to corporate resources, data, services, and physical locations through biometric identity verification. With 42 employees, the company has been listed on the stock market since 1997.

Frequently asked questions about BIO-Key International

Analysts currently set an average price target of 2.04 USD for the BIO-Key International stock (median: 2.04 USD), implying -26.1 % versus the latest price. The consensus is based on 7 analyst ratings.

7 analysts currently rate the BIO-Key International stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect BIO-Key International to generate revenue of 9.00 M USD and earnings per share of -26.53 USD.

Converted at the current exchange rate, the BIO-Key International share trades at 2.46 EUR (2.76 USD).

The BIO-Key International share (BKYI) is listed on 2 stock exchanges, including: NASDAQ (BKYI), Frankfurt (BJO.F).

The expected revenue of BIO-Key International is 9.00 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of BIO-Key International is -17.56 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of BIO-Key International is currently -0.10. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the BIO-Key International stock.

The price-to-sales ratio (P/S) of BIO-Key International is currently 0.20. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the BIO-Key International stock.

The Eulerpool Quality Score for BIO-Key International is 2/10.

The ISIN of BIO-Key International is US09060C5076. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of BIO-Key International is A2QJDQ. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of BIO-Key International is BKYI. The ticker symbol is used to trade BIO-Key International shares on the stock exchange.

Fair ValueTerminal
2.54 USD
Over-/UndervaluationTerminal
Fairly valued
Industry
Software
Number of shares
Employees
Revenue per Employee
145,121.83 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website bio-key.com
Currency
USD
Initial public offering
Apr 17, 1997
ISIN
US09060C5076
Cusip
09060C408
Sedol
BMC7ML7
Market capitalization
29.93 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-0.10
P/Ee 2027
12.55
P/S
P/Se
0.20
EV/EBIT
—
P/B Ratio
3.90
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-54.83 %
Last updated Oct 18, 2026, 8:21 PM

BIO-Key International Ticker

FRANKFURT · BJO.FNASDAQ · BKYI